3 Minutes
Dreams that turn into actions can be the first red flag. Some people begin physically acting out dreams—kicking, flailing, or speaking—long before a tremor ever appears. That behavior, known as REM sleep behavior disorder, is one of several subtle, nonmotor changes clinicians now link to the earliest phase of Parkinson’s disease.
New molecular signals in prodromal Parkinson’s
Researchers at Chalmers University of Technology and Oslo University Hospital report that molecular signatures tied to DNA repair shift as Parkinson’s progresses from prodromal (early, pre-motor) stages to established disease. The longitudinal study, published in npj Parkinson’s Disease (Anwer et al., DOI: 10.1038/s41531-025-01194-7), followed patient samples over time to map how these signals evolve.
Before the classic motor signs—slowness, stiffness, balance problems and tremor—people may experience a diminished sense of smell, persistent constipation, anxiety, or depression. These symptoms are easy to overlook. They do not scream "Parkinson’s," but together they form a pattern that clinicians call prodromal Parkinson’s. The new work suggests that alongside these clinical cues, measurable shifts in DNA repair pathways may mark the transition toward neurodegeneration.
Why does this matter? Because molecular markers that emerge early could widen the window for intervention. If clinicians can combine behavioral clues—like REM sleep behavior disorder and anosmia—with blood- or tissue-based molecular readouts, screening and monitoring become far more informed. The study emphasizes the value of repeated sampling over years; a single snapshot misses the trajectory.
Detecting nonmotor signs early could shift Parkinson’s care toward prevention rather than reaction.
The analysis is not a diagnostic silver bullet. Larger cohorts and diverse populations are needed to validate which DNA repair features reliably predict progression. Still, the research points to a practical strategy: watch for mood changes, bowel habits, smell loss and dream enactment, and consider molecular testing when those signs cluster.
If you or a loved one notice persistent, unexplained changes in sleep behavior, smell, mood, or bowel function, bring them up with a clinician—early attention may matter more than we once thought.
Source: scitechdaily
Leave a Comment